High-Purity NAD+ Now at Promotional Pricing

 

 

PT-141 (Bremelanotide) Research Guide — Canada (2025–2026)

 

What Is PT-141?

PT-141 (Bremelanotide) is a synthetic peptide derived from the melanocortin system, particularly targeting MC1R and MC4R receptors. [1, 2]
It has become one of the most studied peptides in behavioral, neurological, and melanocortin research models.

Unlike many pathways that act indirectly, PT-141 interacts directly with neural melanocortin receptors — making it valuable for labs studying:

PT-141 is not a PDE-5 analogue and operates through a completely different research mechanism.


How PT-141 Works (Mechanistically)

Research models suggest PT-141 may influence:

1. MC4R Activation [1, 3]

A key melanocortin receptor involved in:

2. MC1R Activity

Associated with:

3. Direct Neurological Pathway Engagement

PT-141 is of high interest in neuroscience labs because it interacts centrally, not peripherally.

This sets it apart from many other peptides and makes it valuable for research into:


Current Areas of Scientific Interest (Preclinical Only)

PT-141 appears in preclinical literature focused on:

All discussion remains strictly academic and preclinical.


Molecular Profile

Property Details
Peptide name PT-141 (Bremelanotide)
Class Melanocortin receptor peptide
CAS 189691-06-3
Sequence Ac-Nle-c[Asp-His-DNal(2’)-Arg-Trp-Lys]-OH
Research targets MC1R, MC4R

Why PT-141 Is Popular in Canadian Research Labs

Researchers often choose PT-141 because:

Its distinct mechanism makes it a unique candidate for receptor-level investigation.


Storage & Handling


PT-141 vs. Kisspeptin (Quick Comparison)

Feature PT-141 Kisspeptin
Primary receptors MC1R / MC4R GPR54
Research category Melanocortin Hypothalamic
CNS involvement Strong Moderate
Pathway type Direct receptor agonist GnRH-linked modulation

PT-141 is uniquely melanocortin-focused, making it valuable in neurological receptor research.


FAQ (Research-Focused)

Is PT-141 legal to purchase in Canada?

Yes — for research use only.
It is not for human use or medical applications.

Is it similar to PDE-5 analogs?

No.
PT-141 works through melanocortin receptors, not nitric-oxide or vascular pathways.

Who typically uses PT-141?

 

🔬 Research References 

[1] Shadiack, A. M., et al. (2007). PT-141: a melanocortin agonist for the treatment of sexual dysfunction. Pharmacology Biochemistry and Behavior.

[2] Palatin Technologies. (2019). Vyleesi (Bremelanotide) FDA Approval and Mechanism. U.S. Food and Drug Administration.

[3] Argiolas, A., et al. (2012). The melanocortin system in the regulation of sexual function: a current perspective. Neuroscience & Biobehavioral Reviews.

[4] Diamond, E., et al. (2025). The Neurobiology of Bremelanotide for the Treatment of Hypoactive Sexual Desire Disorder in Premenopausal Women. Clinical Therapeutics.

 

Explore More Peptide Research Guides

 

0
    0
    Your Cart
    Your cart is emptyReturn to Shop

    Unlock 10% Off Your First Order

    Join our list and get an instant 10% discount code — valid for first-time buyers.